Inventiva (IVA) Other Accumulated Expenses (2019 - 2025)
Inventiva's (IVA) quarterly Other Accumulated Expenses came in at $17.2 billion in Q2 2025, up 273225.25% year-on-year from N/an in Q2 2024, and up 86.86% quarter-over-quarter from $9.2 billion in Q4 2024.
Inventiva (IVA) Other Accumulated Expenses (2019 - 2025) Analysis & Trends
Inventiva's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $17.2 billion for Q2 2025.
- On a quarterly basis, Other Accumulated Expenses rose 273225.25% year-over-year to $17.2 billion in Q2 2025; TTM through Jun 2025 was $17.2 billion, a 273225.25% increase from a year earlier, with the FY2024 full-year figure at $9.2 billion, up 119108.59% from the prior year.
- Other Accumulated Expenses grew to $17.2 billion in Q2 2025 per IVA's latest filing, from $9.2 billion in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $17.2 billion in Q2 2025 and bottomed at $5.4 million in Q2 2023.
- The 5-year median for Other Accumulated Expenses is $8.2 million (2023), against an average of $3.9 billion.
- Across the five-year window, Other Accumulated Expenses tumbled 99.93% in 2022 and surged 273225.25% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $7.8 billion in 2021, then tumbled by 99.93% to $5.6 million in 2022, then jumped by 37.76% to $7.7 million in 2023, then soared by 119108.59% to $9.2 billion in 2024, then surged by 86.86% to $17.2 billion in 2025.
- Per Business Quant, the three latest IVA Other Accumulated Expenses figures stand at $17.2 billion (Q2 2025), $9.2 billion (Q4 2024), and $6.3 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Inventiva | 854.62 Mn | 854.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 17.17 Bn |
| Dec 31, 2024 | 9.19 Bn |
| Jun 30, 2024 | 6.28 Mn |
| Dec 31, 2023 | 7.71 Mn |
| Jun 30, 2023 | 5.42 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Jun 30, 2022 | 5.01 Bn |
| Dec 31, 2021 | 7.77 Bn |
| Jun 30, 2021 | 5.43 Mn |
| Mar 31, 2021 | 8.71 Mn |
| Dec 31, 2020 | 8.15 Mn |
| Jun 30, 2020 | 5.88 Mn |
| Dec 31, 2019 | 5.53 Mn |